Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Pharmacogenetics of the human beta-adrenergic receptors

The Pharmacogenomics Journal volume 7, pages 29–37 (2007)Cite this article

Abstract

The beta-adrenergic receptors (ADRBs) are cell surface receptors that play central roles in the sympathetic nervous system. Pharmacological targeting of two of these receptors, ADRB1 and ADRB2, represents a widely used therapeutic approach for common and important diseases including asthma, hypertension and heart failure. Genetic variation in both ADRB1 and ADRB2 has been linked to both in vitro and clinical disease phenotypes. More recently, interest has shifted to studies that explore potential interaction between variation in ADRBs and medications directed at these important receptors. This paper reviews the current state of knowledge and understanding of ADRB genetic variation and explores the likely direction of future studies in this area.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Busse W, Banks-Schlegel S, Noel P, Ortega H, Taggart V, Elias J . Future research directions in asthma: an NHLBI Working Group report. Am J Respir Crit Care Med 2004; 170: 683–690.

    Article  PubMed  Google Scholar 

  2. Palmer LJ, Burton PR, James AL, Musk AW, Cookson WO . Familial aggregation and heritability of asthma-associated quantitative traits in a population-based sample of nuclear families. Eur J Hum Genet 2000; 8: 853–860.

    Article  CAS  PubMed  Google Scholar 

  3. Palmer LJ, Cookson WO . Genomic approaches to understanding asthma. Genome Res 2000; 10: 1280–1287.

    Article  CAS  PubMed  Google Scholar 

  4. Palmer LJ, Silverman ES, Weiss ST, Drazen JM . Pharmacogenetics of asthma. Am J Respir Crit Care Med 2002; 165: 861–866.

    Article  PubMed  Google Scholar 

  5. Fuster V, Wayne A, O'Rourke R (eds). Hurst's The Heart, 11th edn McGraw-Hill: New York, 2004.

    Google Scholar 

  6. Port JD, Bristow MR . Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J Mol Cell Cardiol 2001; 33: 887–905.

    Article  CAS  PubMed  Google Scholar 

  7. Bristow MR . Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol 1993; 22(4 Suppl A): 61A–71A.

    Article  CAS  PubMed  Google Scholar 

  8. Esler M, Kaye D, Lambert G, Esler D, Jennings G . Adrenergic nervous system in heart failure. Am J Cardiol 1997; 80: 7L–14L.

    Article  CAS  PubMed  Google Scholar 

  9. Tonolo G, Melis MG, Secchi G, Atzeni MM, Angius MF, Carboni A et al. Association of Trp64Arg beta 3-adrenergic-receptor gene polymorphism with essential hypertension in the Sardinian population. J Hypertens 1999; 17: 33–38.

    Article  CAS  PubMed  Google Scholar 

  10. Vendrell J, Gutierrez C, Broch M, Fernandez-Real JM, Aguilar C, Richart C . Beta 3-adrenoreceptor gene polymorphism and leptin. Lack of relationship in type 2 diabetic patients. Clin Endocrinol (Oxf) 1998; 49: 679–683.

    Article  CAS  Google Scholar 

  11. Weiser M, Frishman WH, Michaelson MD, Abdeen MA . The pharmacologic approach to the treatment of obesity. J Clin Pharmacol 1997; 37: 453–473.

    Article  CAS  PubMed  Google Scholar 

  12. Gauthier C, Langin D, Balligand JL . Beta3-adrenoceptors in the cardiovascular system. Trends Pharmacol Sci 2000; 21: 426–431.

    Article  CAS  PubMed  Google Scholar 

  13. Gauthier C, Leblais V, Moniotte S, Langin D, Balligand JL . The negative inotropic action of catecholamines: role of beta3-adrenoceptors. Can J Physiol Pharmacol 2000; 78: 681–690.

    Article  CAS  PubMed  Google Scholar 

  14. Taylor MR, Bristow MR . The emerging pharmacogenomics of the beta-adrenergic receptors. Congest Heart Fail 2004; 10: 281–288.

    Article  CAS  PubMed  Google Scholar 

  15. Lelias JM, Kaghad M, Rodriguez M, Chalon P, Bonnin J, Dupre I et al. Molecular cloning of a human beta 3-adrenergic receptor cDNA. FEBS Lett 1993; 324: 127–130.

    Article  CAS  PubMed  Google Scholar 

  16. Granneman JG, Lahners KN, Rao DD . Rodent and human beta 3-adrenergic receptor genes contain an intron within the protein-coding block. Mol Pharmacol 1992; 42: 964–970.

    CAS  PubMed  Google Scholar 

  17. van Spronsen A, Nahmias C, Krief S, Briend-Sutren MM, Strosberg AD, Emorine LJ . The promoter and intron/exon structure of the human and mouse beta 3-adrenergic-receptor genes. Eur J Biochem 1993; 213: 1117–1124.

    Article  CAS  PubMed  Google Scholar 

  18. Johnson JA, Terra SG . beta-Adrenergic receptor polymorphisms: cardiovascular disease associations and pharmacogenetics. Pharm Res 2002; 19: 1779–1787.

    Article  CAS  PubMed  Google Scholar 

  19. Farfel Z, Bourne HR, Iiri T . The expanding spectrum of G protein diseases. N Engl J Med 1999; 340: 1012–1020.

    Article  CAS  PubMed  Google Scholar 

  20. Moore JD, Mason DA, Green SA, Hsu J, Liggett SB . Racial differences in the frequencies of cardiac beta(1)-adrenergic receptor polymorphisms: analysis of c145A>G and c1165G>C. Hum Mutat 1999; 14: 271.

    Article  CAS  PubMed  Google Scholar 

  21. Podlowski S, Wenzel K, Luther HP, Muller J, Bramlage P, Baumann G et al. Beta1-adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy? J Mol Med 2000; 78: 87–93.

    Article  CAS  PubMed  Google Scholar 

  22. Borjesson M, Magnusson Y, Hjalmarson A, Andersson B . A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J 2000; 21: 1853–1858.

    Article  CAS  PubMed  Google Scholar 

  23. Bengtsson K, Orho-Melander M, Melander O, Lindblad U, Ranstam J, Rastam L et al. Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension 2001; 37: 1303–1308.

    Article  CAS  PubMed  Google Scholar 

  24. Bengtsson K, Melander O, Orho-Melander M, Lindblad U, Ranstam J, Rastam L et al. Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Circulation 2001; 104: 187–190.

    Article  CAS  PubMed  Google Scholar 

  25. Tesson F, Charron P, Peuchmaurd M, Nicaud V, Cambien F, Tiret L et al. Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group. J Mol Cell Cardiol 1999; 31: 1025–1032.

    Article  CAS  PubMed  Google Scholar 

  26. Yamada K, Ishiyama-Shigemoto S, Ichikawa F, Yuan X, Koyanagi A, Koyama W et al. Polymorphism in the 5′-leader cistron of the beta2-adrenergic receptor gene associated with obesity and type 2 diabetes. J Clin Endocrinol Metab 1999; 84: 1754–1757.

    CAS  PubMed  Google Scholar 

  27. Small KM, Wagoner LE, Levin AM, Kardia SL, Liggett SB . Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and. N Engl J Med 2002; 347: 1135–1142.

    Article  CAS  PubMed  Google Scholar 

  28. Reihsaus E, Innis M, MacIntyre N, Liggett SB . Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993; 8: 334–339.

    Article  CAS  PubMed  Google Scholar 

  29. Large V, Hellstrom L, Reynisdottir S, Lonnqvist F, Eriksson P, Lannfelt L et al. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest 1997; 100: 3005–3013.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Buscher R, Eilmes KJ, Grasemann H, Torres B, Knauer N, Sroka K et al. beta2 adrenoceptor gene polymorphisms in cystic fibrosis lung disease. Pharmacogenetics 2002; 12: 347–353.

    Article  PubMed  Google Scholar 

  31. Herrmann SM, Nicaud V, Tiret L, Evans A, Kee F, Ruidavets JB et al. Polymorphisms of the beta2-adrenoceptor (ADRB2) gene and essential hypertension: the ECTIM and PEGASE studies. J Hypertens 2002; 20: 229–235.

    Article  CAS  PubMed  Google Scholar 

  32. Ulbrecht M, Hergeth MT, Wjst M, Heinrich J, Bickeboller H, Wichmann HE et al. Association of beta(2)-adrenoreceptor variants with bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000; 161(2 Part 1): 469–474.

    Article  CAS  PubMed  Google Scholar 

  33. Wood AJ . Variability in beta-adrenergic receptor response in the vasculature: role of receptor polymorphism. J Allergy Clin Immunol 2002; 110(6 Suppl): S318–S321.

    Article  CAS  PubMed  Google Scholar 

  34. Xie HG, Stein CM, Kim RB, Xiao ZS, He N, Zhou HH et al. Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals. Pharmacogenetics 1999; 9: 511–516.

    CAS  PubMed  Google Scholar 

  35. Liggett SB . beta(2)-adrenergic receptor pharmacogenetics. Am J Respir Crit Care Med 2000; 161(3 Part 2): S197–S201.

    Article  CAS  PubMed  Google Scholar 

  36. Liggett SB . Pharmacogenetics of beta-1- and beta-2-adrenergic receptors. Pharmacology 2000; 61: 167–173.

    Article  CAS  PubMed  Google Scholar 

  37. Liggett SB, Wagoner LE, Craft LL, Hornung RW, Hoit BD, McIntosh TC et al. The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 1998; 102: 1534–1539.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. McGraw DW, Forbes SL, Kramer LA, Liggett SB . Polymorphisms of the 5′ leader cistron of the human beta2-adrenergic receptor regulate receptor expression. J Clin Invest 1998; 102: 1927–1932.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Fujisawa T, Ikegami H, Yamato E, Hamada Y, Kamide K, Rakugi H et al. Trp64Arg mutation of beta3-adrenergic receptor in essential hypertension: insulin resistance and the adrenergic system. Am J Hypertens 1997; 10: 101–105.

    Article  CAS  PubMed  Google Scholar 

  40. Hein L . Physiological significance of beta-adrenergic receptor polymorphisms: in-vivo or in-vitro veritas? Pharmacogenetics 2001; 11: 187–189.

    Article  CAS  PubMed  Google Scholar 

  41. Mason DA, Moore JD, Green SA, Liggett SB . A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 1999; 274: 12670–12674.

    Article  CAS  PubMed  Google Scholar 

  42. Maqbool A, Hall AS, Ball SG, Balmforth AJ . Common polymorphisms of beta1-adrenoceptor: identification and rapid screening assay. Lancet 1999; 353: 897.

    Article  CAS  PubMed  Google Scholar 

  43. dbSNP database.

  44. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 2000; 97: 10483–10488.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Chamberlain PD, Jennings KH, Paul F, Cordell J, Berry A, Holmes SD et al. The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: direct evidence of the beta3-adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int J Obes Relat Metab Disord 1999; 23: 1057–1065.

    Article  CAS  PubMed  Google Scholar 

  46. Perfetti R, Hui H, Chamie K, Binder S, Seibert M, McLenithan J et al. Pancreatic beta-cells expressing the Arg64 variant of the beta(3)-adrenergic receptor exhibit abnormal insulin secretory activity. J Mol Endocrinol 2001; 27: 133–144.

    Article  CAS  PubMed  Google Scholar 

  47. Zhang C, Williams MA, Edwards KL, Austin MA . Trp64Arg polymorphism of the beta3-adrenergic receptor gene, pre-pregnancy obesity and risk of pre-eclampsia. J Matern Fetal Neonatal Med 2005; 17: 19–28.

    Article  PubMed  CAS  Google Scholar 

  48. Bachman ES, Dhillon H, Zhang CY, Cinti S, Bianco AC, Kobilka BK et al. betaAR signaling required for diet-induced thermogenesis and obesity resistance. Science 2002; 297: 843–845.

    Article  CAS  PubMed  Google Scholar 

  49. Moniotte S, Kobzik L, Feron O, Trochu JN, Gauthier C, Balligand JL . Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 2001; 103: 1649–1655.

    Article  CAS  PubMed  Google Scholar 

  50. Emorine L, Blin N, Strosberg AD . The human beta 3-adrenoceptor: the search for a physiological function. Trends Pharmacol Sci 1994; 15: 3–7.

    Article  CAS  PubMed  Google Scholar 

  51. Langin D, Tavernier G, Lafontan M . Regulation of beta 3-adrenoceptor expression in white fat cells. Fundam Clin Pharmacol 1995; 9: 97–106.

    Article  CAS  PubMed  Google Scholar 

  52. Allison DB, Heo M, Faith MS, Pietrobelli A . Meta-analysis of the association of the Trp64Arg polymorphism in the beta3 adrenergic receptor with body mass index. Int J Obes Relat Metab Disord 1998; 22: 559–566.

    Article  CAS  PubMed  Google Scholar 

  53. Strosberg AD . Association of beta 3-adrenoceptor polymorphism with obesity and diabetes: current status. Trends Pharmacol Sci 1997; 18: 449–454.

    Article  CAS  PubMed  Google Scholar 

  54. Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med 1995; 333: 343–347.

    Article  CAS  PubMed  Google Scholar 

  55. Garcia-Rubi E, Calles-Escandon J . Insulin resistance and type 2 diabetes mellitus: its relationship with the beta 3-adrenergic receptor. Arch Med Res 1999; 30: 459–464.

    Article  CAS  PubMed  Google Scholar 

  56. Arner P, Hoffstedt J . Adrenoceptor genes in human obesity. J Intern Med 1999; 245: 667–672.

    Article  CAS  PubMed  Google Scholar 

  57. Leineweber K, Buscher R, Bruck H, Brodde OE . Beta-adrenoceptor polymorphisms. Naunyn Schmiedebergs Arch Pharmacol 2004; 369: 1–22.

    Article  CAS  PubMed  Google Scholar 

  58. Rathz DA, Brown KM, Kramer LA, Liggett SB . Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol 2002; 39: 155–160.

    Article  CAS  PubMed  Google Scholar 

  59. Levin MC, Marullo S, Muntaner O, Andersson B, Magnusson Y . The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor. J Biol Chem 2002; 277: 30429–30435.

    Article  CAS  PubMed  Google Scholar 

  60. Green SA, Turki J, Innis M, Liggett SB . Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994; 33: 9414–9419.

    Article  CAS  PubMed  Google Scholar 

  61. Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM et al. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 2001; 345: 1030–1035.

    Article  CAS  PubMed  Google Scholar 

  62. Green SA, Cole G, Jacinto M, Innis M, Liggett SB . A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 1993; 268: 23116–23121.

    Article  CAS  PubMed  Google Scholar 

  63. Turki J, Lorenz JN, Green SA, Donnelly ET, Jacinto M, Liggett SB . Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice. Proc Natl Acad Sci USA 1996; 93: 10483–10488.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Parola AL, Kobilka BK . The peptide product of a 5′ leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis. J Biol Chem 1994; 269: 4497–4505.

    Article  CAS  PubMed  Google Scholar 

  65. Johnatty SE, Abdellatif M, Shimmin L, Clark RB, Boerwinkle E . Beta2 adrenergic receptor 5′ haplotypes influence promoter activity. Br J Pharmacol 2002; 137: 1213–1216.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Ranade K, Jorgenson E, Sheu WH, Pei D, Hsiung CA, Chiang FT et al. A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 2002; 70: 935–942.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Humma LM, Puckett BJ, Richardson HE, Terra SG, Andrisin TE, Lejeune BL et al. Effects of beta1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia. Am J Cardiol 2001; 88: 1034–1037.

    Article  CAS  PubMed  Google Scholar 

  68. Karlsson J, Lind L, Hallberg P, Michaelsson K, Kurland L, Kahan T et al. Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension. Clin Cardiol 2004; 27: 347–350.

    Article  CAS  PubMed  Google Scholar 

  69. Magnusson Y, Levin MC, Eggertsen R, Nystrom E, Mobini R, Schaufelberger M et al. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy. Clin Pharmacol Ther 2005; 78: 221–231.

    Article  CAS  PubMed  Google Scholar 

  70. Mialet Perez J, Rathz DA, Petrashevskaya NN, Hahn HS, Wagoner LE, Schwartz A et al. Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med 2003; 9: 1300–1305.

    Article  PubMed  CAS  Google Scholar 

  71. Wills-Karp M, Ewart SL . Time to draw breath: asthma-susceptibility genes are identified. Nat Rev Genet 2004; 5: 376–387.

    Article  CAS  PubMed  Google Scholar 

  72. Contopoulos-Ioannidis DG, Manoli EN, Ioannidis JP . Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes. J Allergy Clin Immunol 2005; 115: 963–972.

    Article  CAS  PubMed  Google Scholar 

  73. Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004; 364: 1505–1512.

    Article  CAS  PubMed  Google Scholar 

  74. Martinez FD, Graves PE, Baldini M, Solomon S, Erickson R . Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997; 100: 3184–3188.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Rosmond R, Ukkola O, Chagnon M, Bouchard C, Bjorntorp P . Polymorphisms of the beta2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men. J Intern Med 2000; 248: 239–244.

    Article  CAS  PubMed  Google Scholar 

  76. Bray MS, Krushkal J, Li L, Ferrell R, Kardia S, Sing CF et al. Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 2000; 101: 2877–2882.

    Article  CAS  PubMed  Google Scholar 

  77. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 1982; 307: 205–211.

    Article  CAS  PubMed  Google Scholar 

  78. Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R et al. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res 1986; 59: 297–309.

    Article  CAS  PubMed  Google Scholar 

  79. Brodde OE, Schuler S, Kretsch R, Brinkmann M, Borst HG, Hetzer R et al. Regional distribution of beta-adrenoceptors in the human heart: coexistence of functional beta 1- and beta 2-adrenoceptors in both atria and ventricles in severe congestive cardiomyopathy. J Cardiovasc Pharmacol 1986; 8: 1235–1242.

    Article  CAS  PubMed  Google Scholar 

  80. Wagoner LE, Craft LL, Singh B, Suresh DP, Zengel PW, McGuire N et al. Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure. Circ Res 2000; 86: 834–840.

    Article  CAS  PubMed  Google Scholar 

  81. Kaye DM, Smirk B, Finch S, Williams C, Esler MD . Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype. J Am Coll Cardiol 2004; 44: 2008–2015.

    Article  CAS  PubMed  Google Scholar 

  82. Kaye DM, Smirk B, Williams C, Jennings G, Esler M, Holst D . Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. Pharmacogenetics 2003; 13: 379–382.

    Article  CAS  PubMed  Google Scholar 

  83. Brain Jr N, Dominiczak AF . Pharmacogenomics in hypertension: present practicalities and future potential. J Hypertens 2005; 23: 1327–1329.

    Article  CAS  PubMed  Google Scholar 

  84. Mellen PB, Herrington DM . Pharmacogenomics of blood pressure response to antihypertensive treatment. J Hypertens 2005; 23: 1311–1325.

    Article  CAS  PubMed  Google Scholar 

  85. Sandilands A, Yeo G, Brown MJ, O'Shaughnessy KM . Functional responses of human beta1 adrenoceptors with defined haplotypes for the common 389R>G and 49S>G polymorphisms. Pharmacogenetics 2004; 14: 343–349.

    Article  CAS  PubMed  Google Scholar 

  86. Defoor J, Martens K, Zielinska D, Matthijs G, Van Nerum H, Schepers D et al. The CAREGENE study: polymorphisms of the {beta}1-adrenoceptor gene and aerobic power in coronary artery disease. Eur Heart J 2006; 27: 808–816.

    Article  CAS  PubMed  Google Scholar 

  87. Bruck H, Leineweber K, Park J, Weber M, Heusch G, Philipp T et al. Human beta2-adrenergic receptor gene haplotypes and venodilation in vivo. Clin Pharmacol Ther 2005; 78: 232–238.

    Article  CAS  PubMed  Google Scholar 

  88. Oostendorp J, Postma DS, Volders H, Jongepier H, Kauffman HF, Boezen HM et al. Differential desensitization of homozygous haplotypes of the beta2-adrenergic receptor in lymphocytes. Am J Respir Crit Care Med 2005; 172: 322–328.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Petrone A, Zavarella S, Iacobellis G, Zampetti S, Vania A, Di Pietro S et al. Association of beta2 adrenergic receptor polymorphisms and related haplotypes with triglyceride and LDL-cholesterol levels. Eur J Hum Genet 2006; 14: 94–100.

    Article  CAS  PubMed  Google Scholar 

  90. Zee RY, Cook NR, Reynolds R, Cheng S, Ridker PM . Haplotype analysis of the beta2 adrenergic receptor gene and risk of myocardial infarction in humans. Genetics 2005; 169: 1583–1587.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Muszkat M, Stein CM . Pharmacogenetics and response to beta-adrenergic receptor antagonists in heart failure. Clin Pharmacol Ther 2005; 77: 123–126.

    Article  CAS  PubMed  Google Scholar 

  92. Cascorbi I, Paul M, Kroemer HK . Pharmacogenomics of heart failure – focus on drug disposition and action. Cardiovasc Res 2004; 64: 32–39.

    Article  CAS  PubMed  Google Scholar 

  93. La Rosee K, Huntgeburth M, Rosenkranz S, Bohm M, Schnabel P . The Arg389Gly beta1-adrenoceptor gene polymorphism determines contractile response to catecholamines. Pharmacogenetics 2004; 14: 711–716.

    Article  CAS  PubMed  Google Scholar 

  94. Terra SG, Hamilton KK, Pauly DF, Lee CR, Patterson JH, Adams KF et al. Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy. Pharmacogenet Genomics 2005; 15: 227–234.

    Article  CAS  PubMed  Google Scholar 

  95. Terra SG, Pauly DF, Lee CR, Patterson JH, Adams KF, Schofield RS et al. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure. Clin Pharmacol Ther 2005; 77: 127–137.

    Article  CAS  PubMed  Google Scholar 

  96. Litonjua AA, Silverman EK, Tantisira KG, Sparrow D, Sylvia JS, Weiss ST . Beta 2-adrenergic receptor polymorphisms and haplotypes are associated with airways hyperresponsiveness among nonsmoking men. Chest 2004; 126: 66–74.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Ms Sharon Bobel is acknowledged for her assistance with the preparation of the figures.

Author information

Authors and Affiliations

  1. Adult Medical Genetics Program, University of Colorado at Denver and Health Sciences, Aurora, CO, USA

    M R G Taylor

Authors
  1. M R G Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M R G Taylor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taylor, M. Pharmacogenetics of the human beta-adrenergic receptors. Pharmacogenomics J 7, 29–37 (2007). https://doi.org/10.1038/sj.tpj.6500393

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500393

Keywords

This article is cited by

Search

Advanced search

Quick links